Clinical course of macular edema in two cases of interferon-associated retinopathy observed by optical coherence tomography

Japanese Journal of Ophthalmology

Volumn 49, Issue 3, 2005, Pages 231-234

  Shimura, Masahiko ^a,b   Saito, Takae ^a   Yasuda, Kanako ^a,b   Tamai, Makoto ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NTT East Tohoku Hospital   (Japan)

Author keywords

Hypoalbuminemia; Interferon retinopathy; Macular edema; Optical coherence tomography; Thrombocytopenia

Indexed keywords

INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; EYE TOXICITY; HEPATITIS C; HUMAN; HYPOALBUMINEMIA; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINOPATHY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; LEUKEMIA, MYELOID, CHRONIC; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY;

EID: 21144450342     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-004-0176-6     Document Type: Article

References (18)

1. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350-356.
2. Borden EC, Parkinson D. A perspective on the clinical effectiveness and tolerance of interferon-α. Semin Oncol 1998;25 (Suppl 1):3-8.
3. Chambers RB, Downie A, Foote B, Davidorf FH. Interferon-α associated retinopathy. J Am Osteopath Assoc 1997;97:43-45.
4. Kawano T, Shigehara M, Uto H, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996;91:309-313.
5. Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon-associated retinopathy. Br J Ophthalmol 1998;82:323-325.
6. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alpha. Arch Ophthalmol 1995;113:1041-1044.
7. Tokai R, Ikeda T, Miyaura T, Sato K. Interferon-associated retinopathy and cystoid macular edema. Arch Ophthalmol 2001;119:1077-1079.
8. Ikebe T, Nakatsuka K, Goto M, Sakai Y. A case of retinopathy induced by intravenous administration of interferon. Nihon Ganka Kiyo Folia Ophthalmol Jpn 1990;41:2291-2296.
9. Hejny C, Sternberg P, Lawson DH, et al. Retinopathy associated with high-dose interferon alpha-2b therapy. Am J Ophthalmol 2001;131:782-787.
10. Esmaeli B, Loller C, Papadopoulos N, Romaguera J. Interferon-associated retinopathy in asymptomatic cancer patients. Ophthalmology 2001;108:858-860.
11. Murugananthan N, Vodden J, Gray RH. Interferon-associated retinopathy in a diabetic patient. Eye 1999;13:376-377.
12. Wilson RL, Ross RD, Wilson LM, et al. Interferon-associated retinopathy in a young, insulin-dependent diabetic patient. Retina 2000;20:413-415.
13. Saito H, Ebinuma H, Nagata H, et al. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C. Liver 2001;21:192-197.
14. Jain K, Lam WC, Waheeb S, et al. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001;85:1171-1173.
15. Nishikawa H, Ogura Y, Miyamoto K, et al. Interferon alpha induces leukocyte capillary trapping in rat retinal microcirculation. Arch Ophthalmol 1996;114:726-730.
16. Holt JM, Gordon-Smith EC. Retinal abnormalities in disease of the blood. Br J Ophthalmol 1969;53:145-160.
17. Alexander JS, Patton WF, Christman BW, et al. Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro. Am J Physiol 1998;274:H115-H122.
18. Tsuruoka N, Sugiyama M, Tawaragi Y, et al. Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma. Biochem Biophys Res Commun 1988;155:429-435.